Syed Hasan to Cost-Benefit Analysis
This is a "connection" page, showing publications Syed Hasan has written about Cost-Benefit Analysis.
Connection Strength
0.195
-
Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults. Expert Rev Pharmacoecon Outcomes Res. 2018 08; 18(4):371-377.
Score: 0.088
-
Economic evaluation of pharmacist-led medication reviews in residential aged care facilities. Expert Rev Pharmacoecon Outcomes Res. 2017 Oct; 17(5):431-439.
Score: 0.084
-
Cost analysis of type 2 diabetes mellitus treatment in economically developed countries. Expert Rev Pharmacoecon Outcomes Res. 2019 02; 19(1):5-14.
Score: 0.023